SCIENTIFIC BACKGROUND

DMPK

Category:

Myotonic dystrophies are multisystemic diseases with an autosomal dominant inheritance pattern that represent the most common muscular dystrophies in adults. The prevalence of myotonic dystrophy type 1 (DM1) is estimated at 1:8,000. Onset of symptoms, such as myotonia characterized by delayed relaxation of a tense muscle, is most often observed in early adulthood. In addition, there is muscle weakness and fatigue, as well as dysphagia, an elongated face with poor facial expression, cataracts, diabetes mellitus, and cardiac arrythmias; in men there is early development of a bald forehead and testicular atrophy. The clinical presentation of DM1 is categorized into four partially overlapping phenotypes: asymptomatic, mild, classic, and neonatal. The congenital form is characterized by pronounced muscle hypotonia, often clubfoot formation, and is usually associated with respiratory insufficiency difficulty drinking. Psychomotor development is often delayed. This type occurs predominantly when the disease is passed down from the mother and only in DM1.

 

DM1 is caused by a CTG repeat expansion in the non-translated 3' region of the DMPK gene on chromosome 19 which encodes a protein kinase. DM2 (proximal myotonic myopathy), which is important for differential diagnosis, is caused by expansion of a CCTG repeat in intron 1 of the ZNF9 gene on chromosome 3. The phenomenon of anticipation—meaning a decrease in the age of onset of the disease and/or an increase in the severity of symptoms from one generation to the next—is particularly pronounced in DM1. Healthy individuals have 5-36 CTG repeats in the DMPK gene while DM patients have up to approximately 1,000. Children with the congenital type have more than 1,000 repeats.

 

References

Ashizawa et al. 2018, Neurol Clin Pract 8:507 / Pratte et al. 2015, Am J Med Genet A 167A:708 / Turner et al. 2010, J Neurol Neurosurg Psychiatry 81:358 / Schara et al. 2006, Semin Pediatr Neurol 13:71  / Ranum et al. 2004, Am J Hum Genet 74:793 / Larkin et al. 2001, Brain Res Bull 56:389

GENES

DMPK

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Background information on in vitro diagnostic services Laboratory-based testing methods and medical devices play a critical role in diagnosis and ...

Read more

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more